nach oben

Diabetologia

Erschienen in:

01.02.2003 | Review

Control of body weight: a physiologic and transgenic perspective

verfasst von: G. Frühbeck, R Nutr MD PhD, J. Gómez-Ambrosi

Erschienen in: Diabetologia | Ausgabe 2/2003

Einloggen, um Zugang zu erhalten

Excerpt

In mammals, body weight is normally regulated around a set point by coordinated changes in food intake and energy expenditure. These changes are integrated under the influence of specific neural pathways and circulating signals. Almost 50 years ago it was first proposed that circulating signals generated in proportion to body fat stores influence appetite and energy expenditure in a coordinated manner to regulate body weight [1]. Of particular historical value are the classic parabiosis experiments which provided evidence that such circulating signals exist [2]. …

Kennedy GC (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 140:578–592

Coleman DL (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9:294–298PubMed

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouseobese gene and its human homologue. Nature 372:425–432

Frühbeck G, Jebb SA, Prentice AM (1998) Leptin: physiology and pathophysiology. Clin Physiol 18:399–419PubMed

Woods SC, Schwartz MW, Baskin DG, Seeley RJ (2000) Food intake and the regulation of body weight. Annu Rev Psychol 51:255–277CrossRefPubMed

Frühbeck G (2001) A heliocentric view of leptin. Proc Nutr Soc 60:301–318PubMed

Frühbeck G, Gómez-Ambrosi J (2001) Rationale for the existence of additional adipostatic hormones. FASEB J 15:1996–2006CrossRefPubMed

Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol 280: E827–E847PubMed

Inui A (2000) Transgenic study of energy homeostasis equation: implications and confounding influences. FASEB J 14:2158–2170PubMed

10.

Robinson SW, Dinulescu DM, Cone RD (2000) Genetic models of obesity and energy balance in the mouse. Annu Rev Genet 34:687–745CrossRefPubMed

11.

Valet P, Tavernier G, Castan-Laurell, Saulnier-Blache JS, Langin D (2002) Understanding adipose tissue development from transgenic animal models. J Lipid Res 43:835–860PubMed

12.

Ingalls AM, Dickie MM, Snell GD (1950) Obese, a new mutation in the mouse. J Hered 41:317–318

13.

Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153:1127–1128PubMed

14.

Chen H, Charlat O, Tartaglia LA et al. (1996) Evidence that thediabetes gene encodes the leptin receptor : identification of the mutation in the leptin receptor gene in db/db mice. Cell 84:491–495PubMed

15.

Masuzaki H, Paterson J, Shinyama H et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166–2170PubMed

16.

Tecott LH, Sun LM, Akana SF et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374:542–546

17.

Kawaguchi N, Xu X, Tajima R et al. (2002) ADAM 12 protease induces adipogenesis in transgenic mice. Am J Pathol 160:1895–1903PubMed

18.

Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL (1997) Overexpression ofAgrt leads to obesity in transgenic mice. Nat Genet 17:273–274PubMed

19.

Massiera F, Bloch-Faure M, Ceiler D et al. (2001) Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15:2727–2729PubMed

20.

Jones ME, Thorburn AW, Britt KL et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735–12740CrossRefPubMed

21.

Cuénot L (1905) Les races pures et leur combinaisons chez les souris. Arch Zool Expér Génér 3:123–132

22.

Wolff GL, Roberts DW, Mountjoy KG (1999) Physiological consequences of ectopicagouti gene expression: the yellow obese mouse syndrome. Physiol Genomics 1:151–163PubMed

23.

Ohki Hamazaki H, Watase K, Yamamoto K et al. (1997) Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390:165–169CrossRefPubMed

24.

Fain JN, Ballou LR, Bahouth SW (2001) Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 65:199–209CrossRefPubMed

25.

Coleman DL, Eicher EM (1990) Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 81:424–427PubMed

26.

Naggert JK, Fricker LD, Varlamov O et al. (1995) Hyperproinsulinaemia in obesefat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135–142PubMed

27.

Zucker LM, Zucker TF (1961) Fatty, a new mutation in the rat. J Hered 52:275–278

28.

Chua SC Jr, Chung WK, Wu Peng XS et al. (1996) Phenotypes of mousediabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994–996PubMed

29.

Takaya K, Ogawa Y, Hiraoka J et al. (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14:130–131PubMed

30.

Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290–1300CrossRefPubMed

31.

Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR (2000) Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141:4295–4308PubMed

32.

Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (1993) Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed

33.

Cai A, Hyde JF (1999) The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. Endocrinology 140:3609–3614PubMed

34.

Dong ZM, Gutierrez-Ramos JC, Coxon A, Mayadas TN, Wagner DD (1997) A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci USA 94:7526–7530CrossRefPubMed

35.

Wallenius V, Wallenius K, Ahren B et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75–79CrossRefPubMed

36.

Withers DJ, Gutierrez JS, Towery H et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904PubMed

37.

Burks DJ, de Mora JF, Schubert M et al. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377–382CrossRefPubMed

38.

Donahue LR, Beamer WG (1993) Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol 136:91–104PubMed

39.

Chen AS, Marsh DJ, Trumbauer ME et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97–102PubMed

40.

Butler AA, Kesterson RA, Khong K et al. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518–3521PubMed

41.

Huszar D, Lynch CA, Fairchild Huntress V et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131–141PubMed

42.

Brüning JC, Michael MD, Winnay JN et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559–569PubMed

43.

Beattie JH, Wood AM, Newman AM et al. (1998) Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci USA 95:358–363CrossRefPubMed

44.

Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR (1997) Hypogonadism and obesity in mice with a targeted deletion of theNhlh2 gene. Nat Genet 15:397–401PubMed

45.

Brüning JC, Gautam D, Burks DJ et al. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122–2125CrossRefPubMed

46.

Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141:3388–3396PubMed

47.

Cohen P, Zhao C, Cai X et al. (2001) Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113–1121CrossRefPubMed

48.

Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422–1428PubMed

49.

Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066–1070CrossRefPubMed

50.

Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T (1998) Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273:29577–29585PubMed

51.

Majdic G, Young M, Gomez-Sanchez E et al. (2002) Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143:607–614PubMed

52.

Michaud JL, Boucher F, Melnyk A et al. (2001)Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet 10:1465–1473CrossRefPubMed

53.

Reizes O, Lincecum J, Wang Z et al. (2001) Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106:105–116PubMed

54.

Udy GB, Towers RP, Snell RG et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239–7244CrossRefPubMed

55.

Saltó C, Kindblom JM, Johansson C et al. (2001) Ablation of TRa2 and a concomitant overexpression of a1 yields a mixed hypo- and hyperthyroid phenotype in mice. Mol Endocrinol 15:2115–2128PubMed

56.

Pepin MC, Pothier F, Barden N (1992) Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725–728PubMed

57.

Lowell BB, Susulic VS, Hamann A et al. (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742PubMed

58.

Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA 95:15659–15664CrossRefPubMed

59.

Naveilhan P, Hassani H, Canals JM et al. (1999) Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 5:1188–1193CrossRefPubMed

60.

Sainsbury A, Schwarzer C, Couzens M et al. (2002) Y4 receptor knockout rescues fertility inob/ob mice. Genes Dev 16:1077–1088CrossRefPubMed

61.

Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718–721PubMed

62.

Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS (2000) Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA 97:12729–12734CrossRefPubMed

63.

Susulic VS, Frederich RC, Lawitts J et al. (1995) Targeted disruption of the β₃-adrenergic receptor gene. J Biol Chem 270:29483–29492CrossRefPubMed

64.

Cohen P, Miyazaki M, Socci ND, et al. (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240–243CrossRefPubMed

65.

Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613–2616CrossRefPubMed

66.

Maltais LJ, Lane PW, Beamer WG (1984) Anorexia, a recessive mutation causing starvation in preweanling mice. J Hered 75:468–472PubMed

67.

Shimomura I, Hammer RE, Richardson JA et al. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182–3194PubMed

68.

Kopecky J, Clarke G, Enerbäck S, Spiegelman B, Kozak LP (1995) Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96:2914–2923PubMed

69.

Moitra J, Mason MM, Olive M et al. (1998) Life without white fat: a transgenic mouse. Genes Dev 12:3168–3181PubMed

70.

Murray I, Havel PJ, Sniderman AD, Cianflone K (2000) Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141:1041–1049PubMed

71.

Razani B, Combs TP, Wang XB et al. (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277:8635–8647CrossRefPubMed

72.

Wang ND, Finegold MJ, Bradley A et al. (1995) Impaired energy homeostasis in C/EBPα knockout mice. Science 269:1108–1112PubMed

73.

Tanaka T, Yoshida N, Kishimoto T, Akira S (1997) Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J 16:7432–7443CrossRefPubMed

74.

Yamauchi T, Oike Y, Kamon J et al. (2002) Increased insulin sensitivity despite lipodystrophy inCrebbp heterozygous mice. Nat Genet 30:221–226CrossRefPubMed

75.

Tsukiyama-Kohara K, Poulin F, Kohara M et al. (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 7:1128–1132CrossRefPubMed

76.

Blüher M, Michael MD, Peroni OD et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25–38PubMed

77.

Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S (2001)FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106:563–573PubMed

78.

Shuto Y, Shibasaki T, Otagiri A et al. (2002) Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429–1436CrossRefPubMed

79.

Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ (1995) Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377:151–155

80.

Kellendonk C, Eiden S, Kretz O et al. (2002) Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 143:2333–2340PubMed

81.

Anand A, Chada K (2000) In vivo modulation ofHmgic reduces obesity. Nat Genet 24:377–380PubMed

82.

Sainsbury A, Schwarzer C, Couzens M et al. (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 18:8938–8943CrossRef

83.

Hirsch E, Irikura VM, Paul SM, Hirsh D (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008–11013CrossRefPubMed

84.

Yamada M, Miyakawa T, Duttaroy A et al. (2001) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207–212CrossRefPubMed

85.

Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos Flier E (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396:670–674PubMed

86.

Marsh DJ, Weingarth DT, Novi DE et al. (2002) Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99:3240–3245CrossRefPubMed

87.

Ibrahimi A, Bonen A, Blinn WD et al. (1999) Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274:26761–26766CrossRefPubMed

88.

Eto K, Tsubamoto Y, Terauchi Y et al. (1999) Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283:981–985PubMed

89.

McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595–601CrossRefPubMed

90.

Clouthier DE, Comerford SA, Hammer RE (1997) Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J Clin Invest 100:2697–2713PubMed

91.

Martínez-Botas J, Anderson JB, Tessier D et al. (2000) Absence of perilipin results in leanness and reverses obesity inLepr ^db/db mice. Nat Genet 26:474–479CrossRefPubMed

92.

Tansey JT, Sztalryd C, Gruia Gray J et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98:6494–6499CrossRefPubMed

93.

Ueno N, Inui A, Iwamoto M et al. (1999) Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 117:1427–1432PubMed

94.

Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS (1996) Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 382:622–626PubMed

95.

Fain JN, Ihle JH, Bahouth SW (1999) Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem Biophys Res Commun 263:201–205CrossRefPubMed

96.

Ventre J, Doebber T, Wu M et al. (1997) Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526–1531PubMed

97.

Ogawa Y, Masuzaki H, Hosoda K et al. (1999) Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822–1829PubMed

98.

Clapham JC, Arch JR, Chapman H et al. (2000) Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406:415–418CrossRefPubMed

99.

Bernal-Mizrachi C, Weng S, Li B et al. (2002) Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol 22:961–968CrossRefPubMed

100.

Li B, Nolte LA, Ju J-S et al. (2000) Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med 6:1115–1120CrossRefPubMed

101.

Hahm S, Mizuno TM, Wu TJ et al. (1999) Targeted deletion of theVgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23:537–548PubMed

102.

Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J (1995) Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA 92:8453–8457PubMed

103.

Massiera F, Seydoux J, Geloen A et al. (2001) Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142:5220–5225PubMed

104.

Szczypka MS, Rainey MA, Palmiter RD (2000) Dopamine is required for hyperphagia inLep ^ob/ob mice. Nat Genet 25:102–104CrossRefPubMed

105.

Smith SJ, Cases S, Jensen DR et al. (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lackingDgat. Nat Genet 25:87–90CrossRefPubMed

106.

Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J (2002) E2Fs regulate adipocyte differentiation. Dev Cell 3:39–49PubMed

107.

Miyawaki K, Yamada Y, Ban N, et al. (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738–742CrossRefPubMed

108.

Scrocchi LA, Drucker DJ (1998) Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor^−/− mice. Endocrinology 139:3127–3132PubMed

109.

Weinstock PH, Levak-Frank S, Hudgins LC et al. (1997) Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci USA 94:10261–10266PubMed

110.

Yahagi N, Shimano H, Hasty AH et al. (2002) Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers, but not obesity or insulin resistance inLep ^ob /Lep ^ob mice. J Biol Chem 277:19353–19357CrossRefPubMed

111.

Dinulescu DM, Fan W, Boston BA et al. (1998)Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc Natl Acad Sci USA 95:12707–12712CrossRefPubMed

112.

Erickson JC, Hollopeter G, Palmiter RD (1996) Attenuation of the obesity syndrome ofob/ob mice by the loss of neuropeptide Y. Science 274:1704–1707PubMed

113.

Schreyer SA, Chua SC, Jr., LeBoeuf RC (1998) Obesity and diabetes in TNF-α receptor-deficient mice. J Clin Invest 102:402–411PubMed

114.

Schafer K, Fujisawa K, Konstantinides S, Loskutoff DJ (2001) Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabeticob/ob mice. FASEB J 15:1840–1842PubMed

115.

Kubota N, Terauchi Y, Miki H et al. (1999) PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597–609PubMed

116.

Elchebly M, Payette P, Michaliszyn E et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548CrossRefPubMed

117.

Cheng A, Uetani N, Simoncic PD et al. (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2:497–503PubMed

118.

Goudriaan JR, Tacken PJ, Dahlmans VE et al. (2001) Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol 21:1488–1493PubMed

119.

Soloveva V, Graves RA, Rasenick MM, Spiegelman BM, Ross SR (1997) Transgenic mice overexpressing the β₁-adrenergic receptor in adipose tissue are resistant to obesity. Mol Endocrinol 11:27–38PubMed

120.

Flier JS, Maratos-Flier E (1998) Obesity and the hypothalamus: novel peptides for new pathways. Cell 92:437–440PubMed

121.

Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of feeding. Nature 404:661–671PubMed

122.

Heisler LK, Cowley MA, Tecott LH et al. (2002) Activation of central melanocortin pathways by fenfluramine. Science 297:609–611CrossRefPubMed

123.

Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293–1307PubMed

124.

Mauvais-Jarvis F, Kulkarni RN, Kahn CR (2002) Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol 57:1–9CrossRef

125.

Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339PubMed

126.

Mauvais-Jarvis F, Virkamaki A, Michael MD, et al. (2000) A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes 49:2126–2134PubMed

127.

Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97PubMed

128.

Guerra C, Navarro P, Valverde AM et al. (2001) Brown adipose tissue-specific insulin receptor knockout shows a phenotype without insulin resistance. J Clin Invest 108:1205–1213CrossRefPubMed

129.

Mathews ST, Singh GP, Ranalletta M, et al. (2002) Improved insulin sensitivity and resistance to weight gain in mice null for theAhsg gene. Diabetes 51:2450–2458PubMed

130.

Ikeda A, Chang K-T, Matsumoto Y, et al. (1998) Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 139:3057–3063PubMed

131.

Rask E, Olsson T, Söderberg S et al. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418–1421PubMed

132.

Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ, Walker BR (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560–563PubMed

133.

Ling C, Hellgren G, Gebre-Medhin M, et al. (2000) Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation in PRL-transgenic mice. Endocrinology 141:3564–3572PubMed

134.

Freemark M, Fleenor D, Driscoll P, Binart N, Kelly PA (2001) Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142:532–537PubMed

135.

Havel PJ (2001) Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med 226:963–977

136.

Raguso C, McCullough AJ (2000) Leptin and the gastrointestinal tract. Curr Opin Gastroenterol 16:160–165CrossRef

137.

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660PubMed

138.

Mucciolo G, Tshöp M, Papotti M, Deghenghi R, Heiman M, Ghigo E (2002) Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440:235–254CrossRefPubMed

139.

Yip RGC, Wolfe MM (2000) GIP biology and fat metabolism. Life Sci 66:91–103CrossRefPubMed

140.

Miyawaki K, Yamada Y, Yano H et al. (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96:14843–14847PubMed

141.

Lafontan M, Berlan M (1993) Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34:1057–1091PubMed

142.

Bachman ES, Dhillon H, Zhang C-Y et al. (2002) βAR signaling required fot diet-induced thermogenesis and obesity resistance. Science 297:843–845CrossRefPubMed

143.

Valet PD, Grujic J, Wade M et al. (2000) Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity. J Biol Chem 275:34797–34802PubMed

144.

Yu S, Yu D, Lee E et al. (1998) Variable and tissue-specific hormone resistance in heterotrimeric Gs protein α-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the Gsα gene. Proc Natl Acad Sci USA 95:8715–8720CrossRefPubMed

145.

Yu S, Gavrilova O, Chen H et al. (2000) Paternal versus maternal transmission of a stimulatory G protein α-subunit knockout produces opposite effects on energy metabolism. J Clin Invest 105:615–623PubMed

146.

Moxham CM, Malbon CC (1996) Insulin action impaired by deficiency of the G-protein subunit Giα₂. Nature 379:840–844PubMed

147.

Tao J, Malbon CC, Wang H (2001) Gαi2 enhances insulin signalling via suppression of protein-tyrosine phosphatase 1B. J Biol Chem 276:39705–39712CrossRefPubMed

148.

Galvin-Parton PA, Chen X, Moxham CM, Malbon CC (1997) Induction of Gαq-specific antisense RNA in vivo causes increased body mass and hyperadiposity. J Biol Chem 272:4335–4341CrossRefPubMed

149.

Arner P (2000) Hunting for human obesity genes? Look in the adipose tissue. Int J Obes 24: S57–S62

150.

Ioffe E, Moon B, Connolly E, Friedman JM (1998) Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci USA 95:11852–11857CrossRefPubMed

151.

Qiu J, Ogus S, Lu R, Chehab FF (2001) Transgenic mice overexpressing leptin accumulate adipose mass at an older, but not younger age. Endocrinology 142:348–358PubMed

152.

Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610–614

153.

Uysal KT, Wiesbrock SM, Hotamisligil GS (1998) Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α mediated insulin resistance in genetic obesity. Endocrinology 139:4832–4838PubMed

154.

Nisoli E, Briscini L, Giordano A et al. (2000) Tumor necrosis factor α mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci USA 97:8033–8038CrossRefPubMed

155.

Ukkola O (2002) Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 147:571–574PubMed

156.

Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89CrossRefPubMed

157.

Perreault M, Marette A (2001) Targeted disruption of inducible nitric-oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138–1143CrossRefPubMed

158.

Duplain H, Burcelin R, Sartori C et al. (2001) Insulin resistance, hyperlipidemia and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342–345PubMed

159.

Shindo T, Kurihara H, Kuno K et al. (2000) ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 105:1345–1352PubMed

160.

Enerbäck S, Jacobsson A, Simpson EM et al. (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387:90–94

161.

Kopecky J, Hodny Z, Rossmeisl M, Syrovy I, Kozak LP (1996) Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am J Physiol 270: E768–E775PubMed

162.

Tsao T-S, Stenbit AE, Li J et al. (1997) Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J Clin Invest 100:671–677PubMed

163.

Zisman et al. (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924–928PubMed

164.

Stenbit AE, Tsao T-S, Li J et al. (1997) GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3:1096–1101PubMed

165.

Abel ED, Peroni O, Kim JK et al. (2001) Adipose-selective targeting of Glut4 gene impairs insulin action in muscle and liver. Nature 409:729–733PubMed

166.

Jong MC, Gijbels MJ, Dahlmans VE et al. (1998) Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 101:145–152PubMed

167.

Castellani LW, Goto AM, Lusis AJ (2001) Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 50:643–651PubMed

168.

Weinstock PH, Bisgaier CL, Aalto-Setälä et al. (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J Clin Invest 96:2555–2568PubMed

169.

Chen HC, Farese RV Jr (2002) Fatty acids, triglycerides, and glucose metabolism: recent insights from knockout mice. Curr Opin Clin Nutr Metab Care 5:359–363CrossRefPubMed

170.

Febbraio M, Abumrad NA, Hajjar DP et al. (1999) A null mutation in CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055–19062PubMed

171.

Cases S, Stone S, Zhou P et al. (2001) Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 276:38870–38876CrossRefPubMed

172.

Tomlinson E, Fu L, John L et al. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741–1747PubMed

173.

Osuga JS, Ishibashi S, Oka T et al. (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USa 97:787–792CrossRefPubMed

174.

Haemmerle G, Zimmermann R, Strauss JG et al. (2002) Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J Biol Chem 277:12946–12952CrossRefPubMed

175.

Kraemer FB, Shen W-J (2002) Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 43:1585–1594CrossRefPubMed

176.

Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM (1996) Uncopupling of obesity from insulin resistance through a targeted mutation inaP2, the adipocyte fatty acid binding protein. Science 274:1377–1379CrossRefPubMed

177.

Coe NR, Simpson MA, Bernlohr DA (1999) Targeted disruption of the adipocyte lipid-binding (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40:967–972PubMed

178.

Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK (2000) Adipocyte metabolism in adipocyte fatty acid binding protein knockout (aP2^−/−) mice after short-term high-fat feeding: functional compensation by keratinocyte fatty acid binding protein. Diabetes 49:904–911PubMed

179.

Kozak LP, Kozak UC, Clarke GT (1991) Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev 5:2256–2264PubMed

180.

Hammond LE, Gallagher PA, Wang S et al. (2002) Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 22:8204–8214CrossRefPubMed

Titel: Control of body weight: a physiologic and transgenic perspective
verfasst von: G. Frühbeck, R Nutr MD PhD
J. Gómez-Ambrosi
Publikationsdatum: 01.02.2003
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 2/2003
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-003-1053-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Control of body weight: a physiologic and transgenic perspective

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2003

Free Fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15–34 yrs) in the Diabetes Incidence Study in Sweden (DISS)

Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life

Author's reply

Alterations of left ventricular function in women with insulin-dependent diabetes mellitus during pregnancy

Heteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin